GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS
CAUTION: Investigational device. Limited by United States law to investigational use.
Apr 12, 2022
Nominees Announced for 2016 Pioneers in Performance Awards for North America; Online Voting Opens at www.PioneersInPerformance.com
Awards program honors medical specialists advancing therapy and improving patient and clinical performance through active collaboration
FDA Approves GORE® VIABAHN® Endoprosthesis for Revision of the Arteriovenous Access
Flexibility and Durability to Aid Hemodialysis Patients
Gore and AAAneurysm Outreach Partner to Increase Early Detection of Abdominal Aortic Aneurysm (AAA)
New Campaign Will Employ Awareness, Community Outreach, and Patient Screening to Fight AAA
Final Subject Enrolled in Early Feasibility Study of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
Antegrade iteration accepted into study – advancing this branched, all-in-one system
GORE® TIGRIS® Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease
Novel device combines proven technology with modern adaptations to provide support in even the most challenging anatomies
GORE® EXCLUDER® AAA Endoprosthesis Gore Completes Primary Enrollment for the Gore EXCLUDER® Iliac Branch Clinical Study
62 patients enrolled in US investigational device exemption clinical study to assess first complete, low-profile system for managing common iliac artery aneurysms or aorto-iliac aneurysms
Gore Receives FDA Approval for 25 cm GORE® VIABAHN® Endoprosthesis
Longest stent-graft introduced in the United States
Market-leading TEVAR Device is First to Surpass 100,000 Devices Distributed Worldwide
Proven, durable device leads the market, continues to impact lives